(3S,10R,13S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1Hcyclopenta[a]phenanthren-3-yl 2,2,2-trifluoroacetate — Impurity Reference Standard

Name: Spectrasynth Pharmachem Pvt. Ltd.
Address: 34, Shivbhumi Industrial Estate, Vibhag 1, Bakrol Bujrang, Bakrol Circle, Ahmedabad, Gujarat, 382430, IN

Buy (3S,10R,13S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1Hcyclopenta[a]phenanthren-3-yl 2,2,2-trifluoroacetate (CAS 1802323-89-2) impurity reference standard from Spectrasynth Pharmachem. Custom synthesis available — enquire for pricing, COA and availability.

Product Code: SSPC-A00196
CAS No.: 1802323-89-2
Chemical Name: (3S,10R,13S)-10,13-Dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1Hcyclopenta[a]phenanthren-3-yl 2,2,2-trifluoroacetate
Synonyms: Abiraterone Acetate :- In House Impurity; (3S,10R,13S)-10,13-dimethyl-17-(((trifluoromethyl)sulfonyl)oxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl 2,2,2-trifluoroacetate; Abiraterone Impurity 8;
Molecular Formula: C22H26F6O5S
Molecular Weight: 516.5
Appearance: NA
Storage: 2-8°C Refrigerator
Application: (3S,10R,13S)-10,13-dimethyl-17-(trifluoromethylsulfonyloxy)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1Hcyclopenta[a]phenanthren-3-yl 2,2,2-trifluoroacetate is an impurity of Abiraterone, a steroidal cytochrome P 450 17α-hydroxylase-17,20-lyase inhibitor, is currently undergoing phase II clinical trials as a potential drug for the treatment of androgen-dependent prostate cancer.